Abstract
Objective
Marfan syndrome patients with aortic root aneurysms undergo elective aortic root replacement to avoid the life-threatening outcomes of aortic dissection and emergency repair. The long-term implications of failed aortic surveillance leading to acute dissection and emergency repair are poorly defined. We compared the long-term clinical courses of Marfan syndrome patients who survive emergency versus elective proximal aortic surgery.
Methods
The GenTAC Registry is an NIH-funded, multicenter database and biorepository that enrolls patients with genetically triggered thoracic aortic aneurysms. Of the 635 patients with Marfan syndrome enrolled as of March 2011, 194 had undergone proximal aortic replacement. Patients were grouped according to emergent (n=47) or elective (n=147) status at the time of surgery.
Results
Patients in the emergent group were more likely to have incomplete proximal aortic resection; 83% of emergency procedures included aortic root replacement, compared with 95% of elective procedures. At long-term follow-up (mean, >6 years), emergent patients had a higher incidence of chronic dissection of the distal aorta and had significantly larger diameters in distal aortic segments than elective patients. Additionally, emergent patients had undergone more operations (1.31 vs 1.11 procedures/patient; P=0.01) and had lower activity scores on a health-related quality-of-life survey.
Conclusions
For Marfan syndrome patients, failed aortic surveillance and consequent emergency dissection repair have important long-term implications with regard to status of the distal aorta, the need for multiple procedures, and quality of life. These findings emphasize the importance of aortic surveillance and timely elective aortic root aneurysm repair for Marfan syndrome patients.
Marfan syndrome is an autosomal dominant inherited disorder caused by mutations in the gene that encodes fibrillin-1. The syndrome is characterized by systemic connective tissue manifestations involving the ocular, skeletal, and cardiovascular systems, among others. Cardiovascular complications, especially aortic root dissection and rupture, are the most common causes of death; their peak incidence is in the third and fourth decades of life.1–4 The life expectancy of Marfan syndrome patients has dramatically improved since aortic root replacement with a composite prosthetic valve conduit was first reported by Bentall in 1967.5,6 Composite valve graft procedures and valve-sparing aortic root replacement procedures are now routinely performed under elective conditions, with low morbidity and mortality.7–12 Patients with Marfan syndrome typically undergo aortic surveillance with serial imaging of the aortic root and are offered elective aortic root replacement when their aortic root diameter reaches an appropriate size in order to avoid life-threatening aortic dissection and the high morbidity associated with emergency aortic surgery.
Although the immediate risk of aortic dissection and emergency repair for this patient population has been extensively studied, the long-term implications of failed aortic surveillance and emergency dissection repair are poorly defined.13–20 The National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC)21,22 has established a biospecimen repository and bioinformatics infrastructure to enable research to determine best practices for optimal clinical management of genetically triggered thoracic aortic aneurysms and related complications. We used the GenTAC Registry to compare the long-term clinical course of Marfan syndrome patients who survive emergency versus elective proximal aortic surgery.
MATERIALS AND METHODS
GenTAC Registry
The GenTAC Registry contains longitudinal observational data on patients with conditions related to genetically induced thoracic aortic aneurysms.21,22 It also has a biospecimen repository and bioinformatics infrastructure created to support research to determine the optimal clinical management of genetically triggered thoracic aortic aneurysms and related complications. The National Heart Lung and Blood Institute and the National Institute of Arthritis and Musculoskeletal and Skin Diseases are co-sponsors of GenTAC.
Patients included in this study were recruited from 5 regional clinical centers that treat patients from a wide geographic catchment area within the United States: Johns Hopkins University, Oregon Health & Science University, University of Pennsylvania, University of Texas Health Science Center at Houston/Baylor College of Medicine, and Weill Cornell Medical College. Research Triangle Institute International serves as the data coordinating center responsible for data management, coordination of training, logistics, and statistical design and analysis.
The targeted enrollment of patients includes adults and children who fall into 1 or more of 12 diagnosis categories, including Marfan syndrome, Loeys-Dietz syndrome, vascular Ehlers-Danlos syndrome, Turner syndrome, bicuspid aortic valve with ascending aortic aneurysm, and familial thoracic aortic aneurysm and dissection. Available clinical data, imaging results, and blood and tissue samples from each patient are processed and stored by GenTAC to provide a resource that combines clinical and biological data from a large and diverse population of patients with inherited thoracic aortic aneurysm disorders.
Patients
From the 635 patients with Marfan syndrome who were enrolled in GenTAC as of March 2011, we selected those who had undergone proximal aortic replacement procedures. Our analyses focused on procedure information, imaging findings, and quality of life, which was measured with the Activity Score of the SF-36 Health Survey23 and the Karnofsky Performance Status Score.24
Analysis
We used SAS software (SAS Institute, Inc.; Cary, NC) to extract data from the secure enterprise network database to create reports and summary tables and to perform ad hoc statistical analyses. To examine between-group differences in continuous outcomes, we used t-tests when tests of normality confirmed that the outcomes data were normally distributed. Wilcoxon rank-sum tests were used when continuous outcome data did not follow a normal distribution. To examine between-group differences in categorical outcomes, we used χ2 tests unless the sample sizes were small, in which case Fisher exact tests were performed. For data security purposes, all analyses were performed and all data were stored in a password-protected remote workspace.
Institutional Review Boards and Consent
Institutional Review Board approval was obtained for this study at each of the 5 participating GenTAC regional clinical centers. Individual informed consent was obtained from each GenTAC Registry patient.
RESULTS
At the time of the analysis, 635 patients with Marfan syndrome were enrolled in GenTAC. Of these, 194 (31%) had undergone 225 proximal aortic surgical procedures at the time of their enrollment. The patients were divided into two groups (Table 1): those whose initial operation was performed emergently for dissection (n=47), and those whose operation was performed electively or urgently for aneurysm and/or aortic regurgitation (n=147). Patients in both groups were predominantly white, middle-aged or young adult males. Patients in the emergent group had a significantly higher prevalence of tobacco use (59% vs 32%, P=0.003). The elective patients were younger than the emergent patients at the time of initial surgery (mean age, 34.9 vs 38.0 years), but this difference was not statistically significant (P=0.2).
TABLE 1.
Demographics
Demographic variable | Group
|
P value | |
---|---|---|---|
Emergent (n=47) | Elective (n=147) | ||
Age at enrollment (y) | 0.6 | ||
<5 | 0 | 0 | |
5–17 | 1 (2) | 5 (3) | |
18–39 | 17 (36) | 63 (43) | |
40–69 | 28 (60) | 72 (49) | |
>69 | 1 (2) | 7 (5) | |
Caucasian race | 44 (94) | 138 (94) | 0.9 |
Hispanic ethnicity | 3 (6) | 8 (5) | 0.7 |
Male gender | 30 (64) | 98 (67) | 0.7 |
Height (cm) | 183.4 ± 11.8 (n=45) |
185.8 ± 12.2 (n=141) |
0.3 |
Weight (kg) | 83.0 ± 23.5 (n=45) |
87.1 ± 23.6 (n=141) |
0.3 |
Body surface area (m2) | 2.04 ± 0.31 (n=45) |
2.11 ± 0.32 (n=138) |
0.2 |
History of tobacco use (>100 cigarettes in lifetime) | 23 (59) (n=39) |
34 (32) (n=107) |
0.003 |
Age at first operation (y) | 38.0 ± 11.1 (n=41) |
34.9 ± 14.2 (n=130) |
0.2 |
Continuous data are presented as mean ± SD, and categorical data are presented as number (%).
There were significant differences between the two groups in the types of proximal aortic surgery performed. Aortic root replacement was performed in 95% of initial operations in the elective group, compared with 83% in the emergent group (P=0.01). The reason for this may be related to the absence of a diagnosis of Marfan syndrome at the time that some patients presented with dissection, or it could relate to operator unfamiliarity with performing root replacement in an emergency situation. Of the root-replacement procedures performed in the elective group, 58% were composite valve graft procedures and 42% were valve-sparing procedures; in contrast, only 17% of the root-replacement operations performed in the emergent group were valve-sparing procedures (P<0.0001). Perhaps for this reason, the emergent patients underwent more aortic procedures than the elective patients (1.31 vs 1.11 aortic procedures per patient, respectively; P=0.01). In the emergent group, 26.9% of patients had undergone multiple aortic procedures, compared with 9.9% in the elective group (P=0.003).
We next examined differences in the status of the distal aorta between patients in the emergent and elective groups. For 95 patients (26 emergent, 69 elective), the GenTAC Registry included data from computed tomography or magnetic resonance imaging of the distal aorta performed after each patient’s proximal aortic operation (Table 2). The average length of time between first operation and crosssectional imaging was 6.6 years for the emergent group and 7.2 years for the elective group. Chronic dissection involving any aortic segment distal to the site of repair was significantly more common in the emergent group (73%) than in the elective group (12%; P<0.0001). Although this relationship was found in each individual segment of the distal aorta examined, the incidence of chronic dissection in the transverse aortic arch in the elective group was particularly low (2%) compared with the incidence of dissection in the descending aortic segments (10%) in that group. These data suggest that the proximal aortic procedures performed in this group were effective at preventing Type A aortic dissection but that these patients have a significant ongoing risk for Type B dissection.
TABLE 2.
Frequency of distal aortic involvement with chronic dissection
Distal aortic segment with dissection involvement | Group
|
P value | |
---|---|---|---|
Emergent (n=26) | Elective (n=69) | ||
Any segment of the distal aorta | 19 (73) | 8 (12) | <0.0001 |
Transverse arch | 13 (50) | 1 (2) | <0.0001 |
Descending thoracic aorta | 15 (58) | 7 (10) | <0.0001 |
Thoracoabdominal aortaa | 15 (58) | 7 (10) | <0.0001 |
Abdominal aorta | 15 (58) | 7 (10) | <0.0001 |
Data are presented as number (%).
Evaluated at the level of the diaphragm.
The impact of Type A aortic dissection on the status of the distal aorta was also noted in differences in aortic diameter (as measured by computed tomography and magnetic resonance imaging) between the two groups (Table 3). At long-term follow-up, patients in the emergent group had larger aortic diameters than the elective patients in each aortic segment except the abdominal aorta, where the difference did not reach statistical significance.
TABLE 3.
Diameters of distal aortic segments
Distal aortic segment | Group
|
P value | |||
---|---|---|---|---|---|
Emergent
|
Elective
|
||||
n | Diameter (cm) | n | Diameter (cm) | ||
Transverse arch | 10 | 3.96 ± 1.19 | 26 | 2.98 ± 0.80 | 0.007 |
Descending thoracic aorta | 17 | 4.66 ± 1.42 | 45 | 3.02 ± 1.11 | <0.0001 |
Thoracoabdominal aortaa | 13 | 4.16 ± 1.42 | 17 | 2.89 ± 1.19 | 0.01 |
Abdominal aorta | 12 | 3.88 ± 1.50 | 26 | 3.18 ± 1.08 | 0.1 |
Measured at the level of the diaphragm.
In addition to differences in the status of the distal aorta, patients in the emergent and elective groups differed in terms of quality of life as assessed by questionnaires administered at the time of enrollment in GenTAC (Table 4). The average length of time between first operation and quality-of-life assessment was 4.73 years for the emergent group and 6.34 years for the elective group. Patients in the elective group had higher self-reported Activity Scores on the SF-36 Health Survey (P=0.04) and marginally higher self-reported Karnofsky Performance Status Scores (P=0.06).
TABLE 4.
Activity scores on quality-of-life measures
Group | |||||
---|---|---|---|---|---|
Measure | Emergent
|
Elective
|
P value | ||
n | Mean | n | Mean | ||
Karnofsky Performance Score | 35 | 82.6 ± 18.7 | 114 | 89.0 ± 12.3 | 0.06 |
SF-36 Health Survey Activity Score | 28 | 12.3 ± 5.4 | 86 | 14.7 ± 5.2 | 0.04 |
DISCUSSION
In this study, we showed that for Marfan syndrome patients, failed aortic surveillance leading to presentation with Type A dissection has greater long-term adverse effects than elective aortic root replacement. The implications of emergency Type A dissection repair are wide ranging and include higher risk of inadequate aortic root aneurysm resection at the time of initial surgery, less utilization of aortic valve–sparing procedures, and a higher frequency of chronic dissection and aneurysm formation in the distal aorta. Additionally, emergent patients appear to have poorer activity-related quality of life than elective patients in the long term.
As a consequence of these findings, our emergent patients are likely to receive more intensive follow-up and care in the future. In this study, we found that the emergent patients underwent more aortic procedures than the elective patients. Given the higher rate of inadequate aortic root resection and chronic dissection involving the distal aorta in the emergent group, we would expect this difference to grow in the future.20 Quality-of-life measures may also become more disparate if emergent patients are more frequently exposed to the morbidity associated with repeated complex aortic repair procedures.
In this study, the term “failed aortic surveillance” was used to refer to failures that occur at many different steps in the diagnosis and management of Marfan syndrome patients. Unfortunately, the degree of detail currently available through the GenTAC registry does not allow us to determine at which point failure occurred in a given patient. In some instances, failure may have occurred because the patient’s Marfan syndrome was not diagnosed before the patient presented with an acute dissection. Other failures are likely to be due to inadequate or misinterpreted follow-up serial imaging. Additionally, a subset of Marfan syndrome patients present with acute dissection before their aortic root diameter reaches the size (45–50 mm) at which patients are commonly referred for prophylactic, elective aortic root replacement. Each of these types of failure represents an opportunity to improve the monitoring of Marfan syndrome patients to reduce the frequency of presentation with acute aortic dissection and are the subject of ongoing GenTAC research.
An important weakness of this study is that the analysis was limited to GenTAC participants who were survivors of proximal aortic surgery at the time of enrollment. The study therefore underestimates the effects of out-of-hospital death, as well as the higher operative morbidity and mortality associated with acute dissection and emergency repair. In contemporary series, surgical repair of acute Type A aortic dissection has been associated with postoperative mortality rates of 15–28%.13,14,17,25,26 Additionally, we did not include perioperative complications of surgery among the outcomes we studied. Another important limitation of our study is that imaging follow-up was incomplete. This study may underestimate the true incidence of chronic dissection involving the distal aorta in emergent patients because the Registry relies on patient imaging reports that do not necessarily describe aortic morphology in a systematic fashion. Phase II of the GenTAC Registry, which will include follow-up for each enrolled patient and an imaging core resource, is expected to address these issues to a large degree and to facilitate more detailed studies of event rates and the behavior of the distal aorta in postoperative Marfan syndrome patients.
Despite these limitations, this study reveals the wide-ranging long-term implications of emergency dissection repair in Marfan syndrome patients with regard to the extent of aortic root resection, the status of the distal aorta, and quality of life. Conversely, elective aortic root replacement was found to be effective prophylaxis against the early, life-threatening risks associated with proximal aortic dissection, as well as the late effects of chronic dissection on the distal aorta. These findings emphasize the importance of aortic surveillance and timely elective aortic root aneurysm repair for Marfan syndrome patients.
Acknowledgments
This work was funded by the National Heart, Lung and Blood Institute Contract Number N01-HV- 08238/HHSN268201000048C.
The authors gratefully acknowledge Stephen N. Palmer, PhD, ELS, for providing editorial support.
Footnotes
The authors have no potential conflicts of interest to report.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Dietz HC, Cutting GR, Pyeritz RE, Maslen CL, Sakai LY, Corson GM, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature. 1991;352:337–9. doi: 10.1038/352337a0. [DOI] [PubMed] [Google Scholar]
- 2.Keane MG, Pyeritz RE. Medical management of Marfan syndrome. Circulation. 2008;117:2802–13. doi: 10.1161/CIRCULATIONAHA.107.693523. [DOI] [PubMed] [Google Scholar]
- 3.Ramirez F, Dietz HC. Marfan syndrome: from molecular pathogenesis to clinical treatment. Curr Opin Genet Dev. 2007;17:252–8. doi: 10.1016/j.gde.2007.04.006. [DOI] [PubMed] [Google Scholar]
- 4.Maslen CL, Corson GM, Maddox BK, Glanville RW, Sakai LY. Partial sequence of a candidate gene for the Marfan syndrome. Nature. 1991;352:334–7. doi: 10.1038/352334a0. [DOI] [PubMed] [Google Scholar]
- 5.Saunders KB, Bentall HH. Aneurysm of the aortic root with gross aortic incompetence: successful surgical correction. Proc R Soc Med. 1967;60:726–8. [PMC free article] [PubMed] [Google Scholar]
- 6.Silverman DI, Burton KJ, Gray J, Bosner MS, Kouchoukos NT, Roman MJ, et al. Life expectancy in the Marfan syndrome. Am J Cardiol. 1995;75:157–60. doi: 10.1016/s0002-9149(00)80066-1. [DOI] [PubMed] [Google Scholar]
- 7.David TE, Feindel CM. An aortic valve-sparing operation for patients with aortic incompetence and aneurysm of the ascending aorta. J Thorac Cardiovasc Surg. 1992;103:617–21. discussion 622. [PubMed] [Google Scholar]
- 8.Gott VL, Cameron DE, Alejo DE, Greene PS, Shake JG, Caparrelli DJ, et al. Aortic root replacement in 271 Marfan patients: a 24-year experience. Ann Thorac Surg. 2002;73:438–43. doi: 10.1016/s0003-4975(01)03336-7. [DOI] [PubMed] [Google Scholar]
- 9.Karck M, Kallenbach K, Hagl C, Rhein C, Leyh R, Haverich A. Aortic root surgery in Marfan syndrome: comparison of aortic valve-sparing reimplantation versus composite grafting. J Thorac Cardiovasc Surg. 2004;127:391–8. doi: 10.1016/j.jtcvs.2003.07.049. [DOI] [PubMed] [Google Scholar]
- 10.LeMaire SA, Carter SA, Volguina IV, Laux AT, Milewicz DM, Borsato GW, et al. Spectrum of aortic operations in 300 patients with confirmed or suspected Marfan syndrome. Ann Thorac Surg. 2006;81:2063–78. doi: 10.1016/j.athoracsur.2006.01.070. discussion 2078. [DOI] [PubMed] [Google Scholar]
- 11.Miller DC. Valve-sparing aortic root replacement in patients with the Marfan syndrome. J Thorac Cardiovasc Surg. 2003;125:773–8. doi: 10.1067/mtc.2003.162. [DOI] [PubMed] [Google Scholar]
- 12.Zehr KJ, Orszulak TA, Mullany CJ, Matloobi A, Daly RC, Dearani JA, et al. Surgery for aneurysms of the aortic root: a 30-year experience. Circulation. 2004;110:1364–71. doi: 10.1161/01.CIR.0000141593.05085.87. [DOI] [PubMed] [Google Scholar]
- 13.David TE, Armstrong S, Ivanov J, Barnard S. Surgery for acute type A aortic dissection. Ann Thorac Surg. 1999;67:1999–2001. doi: 10.1016/s0003-4975(99)00353-7. discussion 2014-9. [DOI] [PubMed] [Google Scholar]
- 14.Kallenbach K, Oelze T, Salcher R, Hagl C, Karck M, Leyh RG, et al. Evolving strategies for treatment of acute aortic dissection type A. Circulation. 2004;110:II243–9. doi: 10.1161/01.CIR.0000138948.14144.d6. [DOI] [PubMed] [Google Scholar]
- 15.Meng RL, Najafi H, Javid H, Hunter JA, Goldin MD. Acute ascending aortic dissection: surgical management. Circulation. 1981;64:II231–4. [PubMed] [Google Scholar]
- 16.Miller DC, Mitchell RS, Oyer PE, Stinson EB, Jamieson SW, Shumway NE. Independent determinants of operative mortality for patients with aortic dissections. Circulation. 1984;70:I153–64. [PubMed] [Google Scholar]
- 17.Sinatra R, Melina G, Pulitani I, Fiorani B, Ruvolo G, Marino B. Emergency operation for acute type A aortic dissection: neurologic complications and early mortality. Ann Thorac Surg. 2001;71:33–8. doi: 10.1016/s0003-4975(00)01824-5. [DOI] [PubMed] [Google Scholar]
- 18.Tsagakis K, Pacini D, Di Bartolomeo R, Gorlitzer M, Weiss G, Grabenwoger M, et al. Multicenter early experience with extended aortic repair in acute aortic dissection: is simultaneous descending stent grafting justified? J Thorac Cardiovasc Surg. 2010;140:S116–20. doi: 10.1016/j.jtcvs.2010.07.066. discussion S142-6. [DOI] [PubMed] [Google Scholar]
- 19.Wolfe WG, Oldham HN, Rankin JS, Moran JF. Surgical treatment of acute ascending aortic dissection. Ann Surg. 1983;197:738–42. doi: 10.1097/00000658-198306000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Zierer A, Voeller RK, Hill KE, Kouchoukos NT, Damiano RJ, Jr, Moon MR. Aortic enlargement and late reoperation after repair of acute type A aortic dissection. Ann Thorac Surg. 2007;84:479–86. doi: 10.1016/j.athoracsur.2007.03.084. discussion 486-7. [DOI] [PubMed] [Google Scholar]
- 21.Eagle KA, Gen TACC. Rationale and design of the National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC) Am Heart J. 2009;157:319–26. doi: 10.1016/j.ahj.2008.10.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Song HK, Bavaria JE, Kindem MW, Holmes KW, Milewicz DM, Maslen CL, et al. Surgical treatment of patients enrolled in the national registry of genetically triggered thoracic aortic conditions. Ann Thorac Surg. 2009;88:781–7. doi: 10.1016/j.athoracsur.2009.04.034. discussion 787-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.McHorney CA, Ware JE, Jr, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994;32:40–66. doi: 10.1097/00005650-199401000-00004. [DOI] [PubMed] [Google Scholar]
- 24.Karnofsky DA, Borchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM, editor. Evaluation of Chemotherapeutic Agents. New York: Columbia University Press; 1949. pp. 199–205. [Google Scholar]
- 25.Moon MR, Sundt TM, III, Pasque MK, Barner HB, Huddleston CB, Damiano RJ, Jr, et al. Does the extent of proximal or distal resection influence outcome for type A dissections? Ann Thorac Surg. 2001;71:1244–9. doi: 10.1016/s0003-4975(00)02610-2. discussion 1249-50. [DOI] [PubMed] [Google Scholar]
- 26.Lai DT, Miller DC, Mitchell RS, Oyer PE, Moore KA, Robbins RC, et al. Acute type A aortic dissection complicated by aortic regurgitation: composite valve graft versus separate valve graft versus conservative valve repair. J Thorac Cardiovasc Surg. 2003;126:1978–86. doi: 10.1016/s0022-5223(03)01279-0. [DOI] [PubMed] [Google Scholar]